Integra LifeSciences Holdings Corp (IART) stock
IARTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 23, 2026Score 9/308% below fair value
$13.55−0.43 (-3.08%)
Close on Nov 17, 2026Market cap $1.05BP/E 79.7Yield –
Integra LifeSciences cash
Cash and short-term investments held at the end of each period.
Integra LifeSciences's cash was $311.93M at Sep 30, 2026. For fiscal 2025 it was $263.74M, down 3.6% from the year before. Over ten years it grew 18.5% a year on average. The highest annual figure on record is $513.45M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $263.74M | -3.6% |
| FY2024 | Dec 31, 2024 | $273.57M | -11.5% |
| FY2023 | Dec 31, 2023 | $309.10M | -32.3% |
| FY2022 | Dec 31, 2022 | $456.66M | -11.1% |
| FY2021 | Dec 31, 2021 | $513.45M | +9.2% |
| FY2020 | Dec 31, 2020 | $470.17M | +136.4% |
| FY2019 | Dec 31, 2019 | $198.91M | +43.3% |
| FY2018 | Dec 31, 2018 | $138.84M | -20.6% |
| FY2017 | Dec 31, 2017 | $174.94M | +71.4% |
| FY2016 | Dec 31, 2016 | $102.06M | +112.0% |
| FY2015 | Dec 31, 2015 | $48.13M | -32.9% |
| FY2014 | Dec 31, 2014 | $71.73M | -40.5% |
| FY2013 | Dec 31, 2013 | $120.61M | +24.4% |
| FY2012 | Dec 31, 2012 | $96.94M | -3.8% |
| FY2011 | Dec 31, 2011 | $100.81M | -21.7% |
| FY2010 | Dec 31, 2010 | $128.76M | +79.1% |
| FY2009 | Dec 31, 2009 | $71.89M | -60.8% |
| FY2008 | Dec 31, 2008 | $183.55M | +220.1% |
| FY2007 | Dec 31, 2007 | $57.34M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $311.93M | +16.4% |
| Q2 FY2026 | Jun 30, 2026 | $274.08M | +8.1% |
| Q1 FY2026 | Mar 31, 2026 | $265.50M | -2.9% |
| Q4 FY2025 | Dec 31, 2025 | $263.74M | -3.6% |
| Q3 FY2025 | Sep 30, 2025 | $267.88M | -3.5% |
| Q2 FY2025 | Jun 30, 2025 | $253.61M | -14.6% |
| Q1 FY2025 | Mar 31, 2025 | $273.30M | -58.8% |
| Q4 FY2024 | Dec 31, 2024 | $273.57M | -11.5% |
| Q3 FY2024 | Sep 30, 2024 | $277.60M | +1.4% |
| Q2 FY2024 | Jun 30, 2024 | $296.93M | -4.0% |
| Q1 FY2024 | Mar 31, 2024 | $663.10M | +115.7% |
| Q4 FY2023 | Dec 31, 2023 | $309.10M | -32.3% |
| Q3 FY2023 | Sep 30, 2023 | $273.73M | -46.5% |
| Q2 FY2023 | Jun 30, 2023 | $309.19M | -30.9% |
| Q1 FY2023 | Mar 31, 2023 | $307.37M | -24.5% |
| Q4 FY2022 | Dec 31, 2022 | $456.66M | -11.1% |
| Q3 FY2022 | Sep 30, 2022 | $511.94M | +8.9% |
| Q2 FY2022 | Jun 30, 2022 | $447.15M | +12.5% |
| Q1 FY2022 | Mar 31, 2022 | $407.09M | -0.5% |
| Q4 FY2021 | Dec 31, 2021 | $513.45M | +9.2% |
| Q3 FY2021 | Sep 30, 2021 | $470.23M | +18.7% |
| Q2 FY2021 | Jun 30, 2021 | $397.41M | +10.1% |
| Q1 FY2021 | Mar 31, 2021 | $408.98M | +14.3% |
| Q4 FY2020 | Dec 31, 2020 | $470.17M | +136.4% |
| Q3 FY2020 | Sep 30, 2020 | $396.28M | +90.5% |
| Q2 FY2020 | Jun 30, 2020 | $360.98M | +105.0% |
| Q1 FY2020 | Mar 31, 2020 | $357.71M | +127.8% |
| Q4 FY2019 | Dec 31, 2019 | $198.91M | +43.3% |
| Q3 FY2019 | Sep 30, 2019 | $207.98M | +1.0% |
| Q2 FY2019 | Jun 30, 2019 | $176.08M | -4.2% |
| Q1 FY2019 | Mar 31, 2019 | $157.03M | -17.1% |
| Q4 FY2018 | Dec 31, 2018 | $138.84M | -20.6% |
| Q3 FY2018 | Sep 30, 2018 | $205.99M | -57.3% |
| Q2 FY2018 | Jun 30, 2018 | $183.77M | +18.9% |
| Q1 FY2018 | Mar 31, 2018 | $189.40M | +39.9% |
| Q4 FY2017 | Dec 31, 2017 | $174.94M | +71.4% |
| Q3 FY2017 | Sep 30, 2017 | $481.94M | – |
| Q2 FY2017 | Jun 30, 2017 | $154.60M | – |
| Q1 FY2017 | Mar 31, 2017 | $135.40M | – |
| Q4 FY2016 | Dec 31, 2016 | $102.06M | – |
See a number that looks wrong?